SCHEMBL7873739

SCHEMBL7873739

CNC(N)=NC(=O)c1cc2c(C(F)(F)F)cc(Oc3ccncc3)cc2[nH]1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RHEB Q15382 1/20 0.37
KDR P35968 6/20 0.36
RAF1 P04049 7/20 0.35
BRAF P15056 6/20 0.35
MAPK14 Q16539 2/20 0.34
TNNI3K Q59H18 2/20 0.34
SRC P12931 2/20 0.34
ICAM1 P05362 1/20 0.33
SELE P16581 1/20 0.33
ABL1 P00519 2/20 0.33
MKNK1 Q9BUB5 2/20 0.33
MKNK2 Q9HBH9 2/20 0.33
CHEK2 O96017 2/20 0.33
MEN1 O00255 1/20 0.33
PLK4 O00444 1/20 0.33
CIT O14578 1/20 0.33
AURKA O14965 1/20 0.33
MUSK O15146 1/20 0.33
EPHB6 O15197 1/20 0.33
MAPK13 O15264 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7881901 0.90 RHEB (0.41) RHEBRAF1BRAFCHEK2FLT3
SCHEMBL7877449 0.89 RHEB (0.39) RHEBKDRRAF1BRAFCHEK2
SCHEMBL7880742 0.89 SMN1; SMN2 (0.40) RHEBCHEK2IDO1
SCHEMBL7881139 0.89 RAF1 (0.39) RHEBKDRRAF1BRAFMAPK14
SCHEMBL7873348 0.86 RHEB (0.38) RHEBRAF1BRAFCHEK2ARAF
SCHEMBL7873187 0.86 RHEB (0.38) RHEBKDRRAF1BRAFCHEK2
SCHEMBL7877591 0.85 RAF1 (0.33) RHEBRAF1ICAM1SELECHEK2
SCHEMBL7873405 0.85 RAF1 (0.38) RHEBKDRRAF1BRAFMAPK14
SCHEMBL7873654 0.85 RHEB (0.35) RHEBKDRRAF1BRAFAR
SCHEMBL7884287 0.85 MEN1 (0.40) RHEBRAF1BRAFCHEK2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed